Black Rock Inc. Exelixis, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXEL
# of Institutions
574Shares Held
253MCall Options Held
1.45MPut Options Held
1.13M-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.1 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$872 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$569 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$425 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL8.17MShares$304 Million0.63% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...